Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and Webcast
Rhea-AI Summary
Beyond Air (NASDAQ: XAIR) will report third fiscal quarter 2026 financial results for the period ended December 31, 2025 on Friday, February 13, 2026. Management will host a conference call and webcast at 8:00 AM Eastern Time the same day. Investors can join by dialing the domestic number 1-877-407-0784 or the international number 1-201-689-8560 using Conference ID 13758405. A live webcast will be available via the company’s Events page, and an online replay will be posted about one hour after the call.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
XAIR fell 8.47% while peers showed mixed moves: DHAI -27.59%, SINT -1.4%, AIMD -1.6%, INBS +2.59%, NVNO +6.27%. With no peers in the momentum scanner and mixed directions, the move appears stock-specific rather than a broad Medical Devices rotation.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Oct 23 | Earnings call scheduling | Neutral | +4.0% | Announced Q2 FY2026 results release and 4:30 PM ET conference call details. |
| Jul 25 | Earnings call scheduling | Neutral | -3.6% | Set date and time for Q1 FY2026 financial results call and webcast. |
| May 20 | Earnings call scheduling | Neutral | +1.5% | Announced fiscal Q4 and full-year 2025 results release and investor call. |
| Jan 27 | Earnings call scheduling | Neutral | -1.8% | Scheduled fiscal Q3 2025 results release and 4:30 PM ET conference call. |
| Oct 29 | Earnings call scheduling | Neutral | +8.8% | Set timing for fiscal Q2 2025 earnings release and related investor webcast. |
Scheduling earnings calls has historically produced modest, mixed single-day moves around these announcements, with an average move of about 3.93% and no clear directional bias.
Over the past year, Beyond Air has regularly announced financial results conference calls, including fiscal Q2 and Q1 2026, fiscal year-end 2025, and prior quarterly results. These releases, all tagged “conferences,earnings”, typically paired standard dial-in details with timing for quarterly or annual reports. Single-day reactions to these scheduling notices have ranged from modest declines to gains, averaging 3.93%, suggesting traders have treated them as routine updates rather than major catalysts.
Historical Comparison
This scheduling notice mirrors five prior conferences,earnings announcements, where average single-day moves were about 3.93%, indicating routine market reactions to similar calls.
The company has consistently scheduled quarterly and year-end earnings calls, providing a regular cadence of financial updates from fiscal 2025 through fiscal 2026.
Regulatory & Risk Context
Beyond Air has an active Form S-3/A shelf filed on 2025-09-30, amended mainly to update legal opinion exhibits while leaving other terms unchanged. A related 424B3 filing on 2025-12-16 reflects at least one instance of usage under this shelf.
Market Pulse Summary
This announcement simply sets the date and access details for Beyond Air’s Q3 FY2026 earnings call on February 13, 2026 at 8:00 AM ET. Investors may contextualize the upcoming results against prior figures, including Q2 FY2026 revenue of $1.8 million, a $8.3 million net loss, and $10.9 million in cash. Recent financing activities and the active shelf registration underscore that balance sheet developments remain an important risk factor to monitor alongside earnings trends.
Key Terms
nitric oxide medical
webcast technical
AI-generated analysis. Not financial advice.
GARDEN CITY, N.Y., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced that it will report financial results for its third fiscal quarter ended December 31, 2025 on Friday, February 13, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 am Eastern Time the same day.
| Conference Call & Webcast | |
| Friday, February 13th@ 8:00 AM ET | |
| Domestic: | 1-877-407-0784 |
| International: | 1-201-689-8560 |
| Conference ID: | 13758405 |
| Webcast: | A webcast of the live conference call can be accessed by visiting the Events section of the Company’s website (click here) or directly (click here). An online replay will be available on the Company’s website or via the direct link an hour after the call. |
About Beyond Air, Inc.
Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. Beyond Air is currently advancing its other revolutionary LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria (NTM).
Additionally, Beyond Cancer, Ltd., an affiliate of Beyond Air, is investigating ultra-high concentrations of NO with a proprietary delivery system to target certain solid tumors in the pre-clinical setting. For more information, visit www.beyondair.net.
CONTACTS:
Corey Davis, Ph.D.
LifeSci Advisors, LLC
Cdavis@lifesciadvisors.com
(212) 915-2577
FAQ
When will Beyond Air (XAIR) report Q3 fiscal 2026 results?
What time is the Beyond Air (XAIR) Q3 2026 conference call and webcast?
How do I join the Beyond Air (XAIR) conference call by phone?
Where can I access the Beyond Air (XAIR) live webcast and replay?
Will Beyond Air (XAIR) provide a replay of the Q3 2026 earnings call?
What is the conference ID for Beyond Air (XAIR) Q3 2026 earnings call?
